MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-01-29
DOI
10.3389/fimmu.2018.00102
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DNA methylation intratumor heterogeneity in localized lung adenocarcinomas
- (2017) Kelly Quek et al. Oncotarget
- Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumors
- (2017) Martin H. Pedersen et al. OncoImmunology
- Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast Cancer
- (2016) R. Gyanchandani et al. CLINICAL CANCER RESEARCH
- The urgent need to recover MHC class I in cancers for effective immunotherapy
- (2016) Federico Garrido et al. CURRENT OPINION IN IMMUNOLOGY
- Multiregion sequencing reveals the intratumor heterogeneity of driver mutations in TP53-driven non-small cell lung cancer
- (2016) Le-Le Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Early dissemination seeds metastasis in breast cancer
- (2016) Hedayatollah Hosseini et al. NATURE
- Mechanism of early dissemination and metastasis in Her2+ mammary cancer
- (2016) Kathryn L. Harper et al. NATURE
- Evidence of intermetastatic heterogeneity for pathological response and genetic mutations within colorectal liver metastases following preoperative chemotherapy
- (2016) Mylène Sebagh et al. Oncotarget
- Major histocompatibility complex class I expression impacts on patient survival and type and density of immune cells in biliary tract cancer
- (2015) Benjamin Goeppert et al. BRITISH JOURNAL OF CANCER
- Evolution of metastasis revealed by mutational landscapes of chemically induced skin cancers
- (2015) Melissa Q McCreery et al. NATURE MEDICINE
- Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
- (2015) Giulia Siravegna et al. NATURE MEDICINE
- Prognostic value of HLA class I expression in patients with colorectal cancer
- (2015) Yuji Iwayama et al. World Journal of Surgical Oncology
- HLA class I as a predictor of clinical prognosis and CTL infiltration as a predictor of chemosensitivity in ovarian cancer
- (2015) Yoshihiko Hirohashi et al. OncoImmunology
- T Lymphocytes Restrain Spontaneous Metastases in Permanent Dormancy
- (2014) I. Romero et al. CANCER RESEARCH
- New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape
- (2014) Deepak Mittal et al. CURRENT OPINION IN IMMUNOLOGY
- Generation of MHC class I diversity in primary tumors and selection of the malignant phenotype
- (2014) Federico Garrido et al. INTERNATIONAL JOURNAL OF CANCER
- Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
- (2014) J. Zhang et al. SCIENCE
- Intratumor DNA Methylation Heterogeneity Reflects Clonal Evolution in Aggressive Prostate Cancer
- (2014) David Brocks et al. Cell Reports
- Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma
- (2013) Ana B. del Campo et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells
- (2012) Josep Domingo-Domenech et al. CANCER CELL
- MHC class I molecules act as tumor suppressor genes regulating the cell cycle gene expression, invasion and intrinsic tumorigenicity of melanoma cells
- (2012) Cristina Garrido et al. CARCINOGENESIS
- The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells
- (2012) Irene Romero et al. JOURNAL OF PATHOLOGY
- Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation
- (2012) Jennifer Landsberg et al. NATURE
- Immunotherapy eradicates metastases with reversible defects in MHC class I expression
- (2011) Cristina Garrido et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes
- (2011) Rafael Carretero et al. INTERNATIONAL JOURNAL OF CANCER
- The Predictive Value of HLA Class I Tumor Cell Expression and Presence of Intratumoral Tregs for Chemotherapy in Patients with Early Breast Cancer
- (2010) E. M. de Kruijf et al. CLINICAL CANCER RESEARCH
- Polysaccharide Krestin Is a Novel TLR2 Agonist that Mediates Inhibition of Tumor Growth via Stimulation of CD8 T Cells and NK Cells
- (2010) H. Lu et al. CLINICAL CANCER RESEARCH
- Modeling metastasis in the mouse
- (2010) Paula D Bos et al. CURRENT OPINION IN PHARMACOLOGY
- “Hard” and “soft” lesions underlying the HLA class I alterations in cancer cells: Implications for immunotherapy
- (2010) Federico Garrido et al. INTERNATIONAL JOURNAL OF CANCER
- PSK may suppress CD57+ T cells to improve survival of advanced gastric cancer patients
- (2010) Junji Akagi et al. International Journal of Clinical Oncology
- Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma
- (2010) Jo Eyles et al. JOURNAL OF CLINICAL INVESTIGATION
- Distant metastasis occurs late during the genetic evolution of pancreatic cancer
- (2010) Shinichi Yachida et al. NATURE
- HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis
- (2010) Bandoh ONCOLOGY REPORTS
- Alterations of HLA class I expression in human melanoma xenografts in immunodeficient mice occur frequently and are associated with higher tumorigenicity
- (2009) Cristina Garrido et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Systemic Spread Is an Early Step in Breast Cancer
- (2008) Yves Hüsemann et al. CANCER CELL
- Human Leukocyte Antigen Class I, MHC Class I Chain-Related Molecule A, and CD8+/Regulatory T-Cell Ratio: Which Variable Determines Survival of Cervical Cancer Patients?
- (2008) E. S. Jordanova et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started